These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20463612)

  • 21. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
    Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
    J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scoring of late gadolinium enhancement in cardiac magnetic resonance imaging can predict cardiac events in patients with hypertrophic cardiomyopathy.
    Nojiri A; Hongo K; Kawai M; Komukai K; Sakuma T; Taniguchi I; Yoshimura M
    J Cardiol; 2011 Nov; 58(3):253-60. PubMed ID: 21890327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
    Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.
    Flett AS; Hayward MP; Ashworth MT; Hansen MS; Taylor AM; Elliott PM; McGregor C; Moon JC
    Circulation; 2010 Jul; 122(2):138-44. PubMed ID: 20585010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.
    Iles L; Pfluger H; Phrommintikul A; Cherayath J; Aksit P; Gupta SN; Kaye DM; Taylor AJ
    J Am Coll Cardiol; 2008 Nov; 52(19):1574-80. PubMed ID: 19007595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
    Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
    Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
    Petersen SE; Jerosch-Herold M; Hudsmith LE; Robson MD; Francis JM; Doll HA; Selvanayagam JB; Neubauer S; Watkins H
    Circulation; 2007 May; 115(18):2418-25. PubMed ID: 17452610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel imaging techniques for diffuse myocardial fibrosis.
    Sado DM; Flett AS; Moon JC
    Future Cardiol; 2011 Sep; 7(5):643-50. PubMed ID: 21929344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between myocardial fibrosis and the occurrence of atrial fibrillation in hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Pujadas S; Vidal-Perez R; Hidalgo A; Leta R; Carreras F; Barros A; Bayes-Genis A; Subirana MT; Pons-Llado G
    Eur J Radiol; 2010 Aug; 75(2):e88-91. PubMed ID: 20079992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.
    Teraoka K; Hirano M; Ookubo H; Sasaki K; Katsuyama H; Amino M; Abe Y; Yamashina A
    Magn Reson Imaging; 2004 Feb; 22(2):155-61. PubMed ID: 15010107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging.
    Popović ZB; Kwon DH; Mishra M; Buakhamsri A; Greenberg NL; Thamilarasan M; Flamm SD; Thomas JD; Lever HM; Desai MY
    J Am Soc Echocardiogr; 2008 Dec; 21(12):1299-305. PubMed ID: 19041572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An atypical case of cardiomyopathy in a child: hypertrophic or restrictive cardiomyopathy?
    Maki T; Niimura I; Nishikawa T; Sekiguchi M
    Heart Vessels Suppl; 1990; 5():84-7. PubMed ID: 2093723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visual estimation of the extent of myocardial hyperenhancement on late gadolinium-enhanced CMR in patients with hypertrophic cardiomyopathy.
    Doesch C; Huck S; Böhm CK; Michaely H; Fluechter S; Haghi D; Dinter D; Borggrefe M; Papavassiliu T
    Magn Reson Imaging; 2010 Jul; 28(6):812-9. PubMed ID: 20409668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy Registry.
    Webber SA; Lipshultz SE; Sleeper LA; Lu M; Wilkinson JD; Addonizio LJ; Canter CE; Colan SD; Everitt MD; Jefferies JL; Kantor PF; Lamour JM; Margossian R; Pahl E; Rusconi PG; Towbin JA;
    Circulation; 2012 Sep; 126(10):1237-44. PubMed ID: 22843787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations.
    Germans T; Wilde AA; Dijkmans PA; Chai W; Kamp O; Pinto YM; van Rossum AC
    J Am Coll Cardiol; 2006 Dec; 48(12):2518-23. PubMed ID: 17174192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extent of myocardial hyperenhancement on late gadolinium-enhanced cardiovascular magnetic resonance correlates with q waves in hypertrophic cardiomyopathy.
    Papavassiliu T; Flüchter S; Haghi D; Süselbeck T; Wolpert C; Dinter D; Kühl H; Borggrefe M
    J Cardiovasc Magn Reson; 2007; 9(3):595-603. PubMed ID: 17365241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Original report. Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging.
    Bogaert J; Goldstein M; Tannouri F; Golzarian J; Dymarkowski S
    AJR Am J Roentgenol; 2003 Apr; 180(4):981-5. PubMed ID: 12646440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial fibrosis in a patient with apical hypertrophic cardiomyopathy detected by delayed-enhanced magnetic resonance imaging.
    Sato Y; Matsumoto N; Kunimasa T; Matsuo S; Yoda S; Tani S; Kunimoto S; Saito S; Hirayama A
    Int J Cardiol; 2008 Dec; 131(1):e41-3. PubMed ID: 17920709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case 153: atypical tumefactive hypertrophic cardiomyopathy.
    Dillman JR; Mueller GC; Attili AK; Dorfman AL; Ensing GJ; Gordon D
    Radiology; 2010 Jan; 254(1):310-3. PubMed ID: 20032162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.